// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























387 Abstracts

Alcohol consumption and risk of atrial fibrillation - results from the BiomarCaRE Consortium

D Csengeri - European Society of Cardiology (ESC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Clinical value of a non-invasive measurement of increased liver stiffness by using virtual touch quantification for predicting elevated right atrial pressure in heart failure patients

K Omote - European Society of Cardiology (ESC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Direct comparison of prognostic ability of BNP and NT-proBNP for cardiogenic stroke and clinical outcome in patients with stroke

H Tsuchiya - European Society of Cardiology (ESC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

Methadone hydrochloride

ABC-death risk score predicts mortality better than CHA2DS2-VASc score in a contemporary population of hospitalised patients with atrial fibrillation

E Paschou - European Society of Cardiology (ESC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Combination of presepsin, soluble CD14 subtype, and B-type natriuretic peptide predicts six-month mortality in patients hospitalized for worsening heart failure

J Ishii - European Society of Cardiology (ESC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Long-term prognostic significance of renal tubular damage, as assessed by urinary Nacetyl-beta-D-glucosamidase, on admission in patients with acute heart failure

S Funabashi - European Society of Cardiology (ESC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Long-term prognostic significance of liver stiffness non-invasively measured by the virtual touch quantification in patients with acute decompensated heart failure

K Omote - European Society of Cardiology (ESC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

FRAILTY INDEPENDENTLY PREDICTS HOSPITALIZATION BURDEN IN HEART FAILURE WITH PRESERVED EJECTION FRACTION

Mohamed-Ali Sareini - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

ISOLATED CARDIAC MANIFESTATIONS OF HUMAN LEUCOCYTE ANTIGEN B27 (HLA-B27): AN AUTOIMMUNE ENIGMA

Olisaemeka Achike - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

ENDURANCE EXERCISE TRAINING ATTENUATES NATRIURETIC PEPTIDE RELEASE DURING MAXIMAL EFFORT EXERCISE: BIOCHEMICAL CORRELATES OF THE ATHLETE’S HEART

Ankit B. Shah - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ILIAC ARTERY OCCLUSION IN A PATIENT WITH ALLOGRAFT RENAL TRANSPLANT CAUSING REFRACTORY HEART FAILURE AND SIMULATING RENAL ARTERY STENOSIS WITH SOLITARY KIDNEY

Hetavi Mahida - American College of Cardiology (ACC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

What Role Should B-Type Natriuretic Peptide Play in Predicting Late Graft Dysfunction Following Cardiac Transplantation?

Aasim Afzal - Heart Failure Society of America (HFSA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Improvements in Cardiac Biomarkers are Associated with Better Health-Related Quality of Life in Patients with Light Chain Amyloidosis

Kristen McCausland - Heart Failure Society of America (HFSA) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Reversal of cardiac remodelling after treatment of IgG4 related cholangitis

Z.H. Wei - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Ursodeoxycholic acid

A comparison of the predictive ability of cardiovascular biomarkers for requiring long-term care service due to physical and cognitive impairments in an elderly general population

K. Sakata - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

One-year follow up after transcatheter treatment of heart failure with preserved ejection fraction using an inter-atrial implant: a single centre case series

R.J.R. Snijder - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Prognostic value of heart failure before and during the first year after TAVI. Factors determining heart failure after TAVI

R. Gonzalez Ferreiro - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Amino acids kynurenine and quinolinic acid and target organ damage in hypertensive patients - novel insights from the styrian hypertension study

H.B. Brussee - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Prognostic implication of body composition compartments and markers of its metabolism in non-cachectic men with chronic heart failure

B. Putnikovic - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Parathyroid hormone

Incremental prognostic value of cardiac biomarkers in diagnostically naive patients with suspected heart failure - comparison with a clinical base model

S. Demirbas - European Society of Cardiology (ESC) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved